11931 results for "cancer rna-seq"
in 22.67 milliseconds.
-
Harbin Medical University Cancer Hospital Data Access Commitee
Dac EGAC00001000948 -
DAC for study Non-coding RNAs in Breast Cancer
Dac EGAC00001001090 -
UT MD Anderson Cancer Center Genomic Medicine and Leukemia
Dac EGAC00001001252 -
ASAN Center for Cancer Genome Discovery Data Access Commitee
Dac EGAC00001001285 -
ASAN Center for Cancer Genome Discovery Data Access Commitee
Dac EGAC00001001391 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001404 -
Cancer Sequencing Data Access Committee
Dac EGAC00001001428 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001505 -
The data usage policy for epigenomic profile of diverse cancer
Dac EGAC00001001540 -
INSERM U981 Team : Genomics of Non-Melanoma Skin Cancer
Dac EGAC00001001644 -
Princess Margaret Head and Neck Cancer Data Access Committee
Dac EGAC00001001647 -
Imperial College Tumour Immunology group - Surgery and Cancer DAC
Dac EGAC00001001814 -
Division of Cellular Signaling National Cancer Center Research Institute
Dac EGAC00001001909 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001001974 -
MRC Institute of Genetics and Cancer Data Access Committee
Dac EGAC00001002163 -
Data access committee breast cancer whole genome sequencing HRD
Dac EGAC00001002286 -
Leeds institute of Medical Research Bladder Cancer Research Group
Dac EGAC00001002397 -
Southern African Prostate Cancer Study (SAPCS) Data Access Committee
Dac EGAC00001002768 -
Targeted sequence of MDS cases treated with azacitidine
Study EGAS00001007030 -
Single Cell RNAseq of PBMC from renal cancer patients
Dac EGAC00001001605 -
BRCA-deficiency/HRD in individuals with HBOC
Study EGAS00001007258 -
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study EGAS00001006007 -
Enhanced detection of MRD with cfDNA Fragmentomics.
Study EGAS00001007192 -
Primary breast tumor heterogeneity through therapy
Study EGAS00001003168 -
JAK and STAT alterations in CD30 positive LPD
Study EGAS00001004181
